Cationic Nucleic Acid Terminators for Sanger Sequencing Artifacts

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current Sanger dideoxy sequencing methods face challenges due to the preferential incorporation of deoxynucleotides over dideoxynucleotides by non-mutated polymerases, leading to low dideoxynucleotide incorporation and high artifacts in DNA sequencing.

Innovation Solution

A cationically charged nucleic acid terminator is used in combination with a discriminatory polymerase, allowing for equivalent incorporation of deoxynucleotides and dideoxynucleotides, reducing dye terminator artifacts through size-dependent electrophoretic separation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If non-mutated polymerases are used in Sanger sequencing, then deoxynucleotide incorporation is efficient, but dideoxynucleotide incorporation is too low resulting in high artifacts and background

Engineering Contradiction:
Improvesequencing accuracyVSAvoidartifacts and background
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent modifies the charge parameter of dideoxynucleotides by attaching cationic groups, changing their electrophoretic mobility and polymerase interaction properties. This allows differentiation between ddNTPs and dNTPs based on charge, enabling the use of non-mutated polymerases while maintaining reliable sequencing by reducing artifact formation through charge-based discrimination during electrophoresis

Inventive Principle:
Principle #35Parameter changes

2Reliability

If mutated polymerases are used to improve dideoxynucleotide incorporation, then sequencing reliability improves, but device complexity and mutation maintenance requirements increase

Engineering Contradiction:
Improvedideoxynucleotide incorporation efficiencyVSAvoidpolymerase mutation management
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Instead of mutating the polymerase, the patent changes the charge parameter of the dideoxynucleotides themselves. This approach achieves reliable dideoxynucleotide incorporation with non-mutated polymerases by using charge-modified terminators that have altered electrophoretic properties, thereby avoiding the complexity of maintaining and managing mutated polymerase variants

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces cationic groups as intermediaries attached to dideoxynucleotides. These cationic moieties serve as mediators that alter the interaction between polymerases and dideoxynucleotides, enabling efficient incorporation without polymerase mutation, while also providing charge-based discrimination during electrophoresis to identify termination events

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If multiple fluorescent labels are used to distinguish different polynucleotides, then detection precision improves, but manufacturing complexity and cost increase

Engineering Contradiction:
Improvepolynucleotide distinction accuracyVSAvoidlabeled terminator production
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent changes the charge parameter of dideoxynucleotides by attaching cationic groups at different positions or with different characteristics for each base type. This charge-based differentiation enables distinction between different polynucleotides using a single labeling strategy, simplifying manufacturing compared to traditional multi-fluorophore approaches while maintaining high detection precision through charge-to-mass ratio differences

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables accurate DNA sequencing by minimizing artifacts and improving the discrimination between deoxynucleotides and dideoxynucleotides, enhancing the reliability of sequencing results.

Implementation Method 1

separating the reacted cationically charged nucleic acid terminator on the basis of size

Methodology Applied
Scientific EffectElectrophoresis: Electrophoresis

Data Source

PatentUSRE46683E1Nucleic acid terminators incorporating a cationic moiety and methods for their use
Publication Date: 2018.01.23 APPLIED BIOSYSTEMS LLC
  • USRE46683E1 patent drawing
  • USRE46683E1 patent drawing
  • USRE46683E1 patent drawing

AI summary

Disclosed are methods and kits applicable to sequencing methods, such as Sanger dideoxy sequencing methods. The methods and kits disclosed utilize a cationically charged nucleic acid terminator in combination with a discriminatory polymerase.